Ki-67 is a predictor of acromegaly control with octreotide LAR independent of SSTR2 status and relates to cytokeratin pattern

AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression

(2012) Leandro Kasuki et al.   ENDOCRINE-RELATED CANCER

Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway

(2012) Harvinder S. Chahal et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly

(2012) Federico Gatto et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Novel pathway for somatostatin analogs in patients with acromegaly

(2012) Mônica R. Gadelha et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly

(2011) Stine Lyngvi Fougner et al.   CLINICAL ENDOCRINOLOGY

Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly

(2011) Ansgar Heck et al.   CLINICAL ENDOCRINOLOGY

Resistance to Somatostatin Analogs in Acromegaly

(2011) Annamaria Colao et al.   ENDOCRINE REVIEWS

A Consensus on Criteria for Cure of Acromegaly

(2010) A. Giustina et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Low Aryl Hydrocarbon Receptor-Interacting Protein Expression Is a Better Marker of Invasiveness in Somatotropinomas than Ki-67 and p53

(2010) Leandro Kasuki Jomori de Pinho et al.   NEUROENDOCRINOLOGY

Analyses of Factors Influencing the Acute Effect of Octreotide in Growth Hormone-secreting Adenomas

(2009) Michi NAKASHIMA et al.   ENDOCRINE JOURNAL

Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly

(2009) Leonardo Vieira Neto et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Guidelines for Acromegaly Management: An Update

(2009) S. Melmed et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

KI-67 IN PITUITARY NEOPLASMS

(2009) Fateme Salehi et al.   NEUROSURGERY

Octreotide LARvs.surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study

(2008) Annamaria Colao et al.   CLINICAL ENDOCRINOLOGY

Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas: Difference among Various Types Defined by Cytokeratin Distribution Pattern Including a Transitional Form

(2008) Abdulkader Obari et al.   ENDOCRINE PATHOLOGY

Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR

(2008) Giselle F Taboada et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

A Critical Analysis of Clinically Available Somatostatin Analog Formulations for Therapy of Acromegaly

(2008) Robert D. Murray et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prognostic Significance of the Ki-67 Labeling Index in Growth Hormone-Secreting Pituitary Adenomas

(2008) A. Fusco et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Correlation ofin Vitroandin VivoSomatotropic Adenoma Responsiveness to Somatostatin Analogs and Dopamine Agonists with Immunohistochemical Evaluation of Somatostatin and Dopamine Receptors and Electron Microscopy

(2008) Diego Ferone et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Low Levels of Raf Kinase Inhibitory Protein in Growth Hormone-Secreting Pituitary Adenomas Correlate with Poor Response to Octreotide Treatment

(2008) Stine Lyngvi Fougner et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas

(2008) Chrysanthia A. Leontiou et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM